Source:http://linkedlifedata.com/resource/pubmed/id/11137238
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9-10
|
pubmed:dateCreated |
2001-1-18
|
pubmed:abstractText |
The availability of single-administration vaccines would assist in the control of global mortality caused by infectious diseases where protection can be achieved only upon repeated immunisations with appropriate vaccines. Biodegradable microspheres of poly(lactide-co-glycolide) have been studied pre-clinically for this purpose and shown to be promising for several protein and sub-unit antigens. In view of preparing a microsphere-based tetanus vaccine for clinical trials, final candidate vaccine-formulations were pre-clinically optimised here. Specifically, the importance of particular materials and processing for the induction of neutralising antibodies in guinea pigs were examined. The most efficacious vaccines were small-sized (<5 microm), co-adjuvanted with admixed alum and fabricated from fast-degrading polymers. Interestingly, the immunogenicity was less influenced by the type of antigen-stabilising excipient, the number of microsphere populations mixed together, or the microencapsulation technology, i.e. spray-drying versus coacervation, used. On the basis of these, we plan to prepare clinical samples for safety and immunogenicity testing in man.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Polyesters,
http://linkedlifedata.com/resource/pubmed/chemical/Polyglycolic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Polymers,
http://linkedlifedata.com/resource/pubmed/chemical/Tetanus Toxoid,
http://linkedlifedata.com/resource/pubmed/chemical/poly(lactide),
http://linkedlifedata.com/resource/pubmed/chemical/polylactic acid-polyglycolic acid...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1047-54
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11137238-Animals,
pubmed-meshheading:11137238-Antibodies, Bacterial,
pubmed-meshheading:11137238-Guinea Pigs,
pubmed-meshheading:11137238-Humans,
pubmed-meshheading:11137238-Immunization,
pubmed-meshheading:11137238-Lactic Acid,
pubmed-meshheading:11137238-Microspheres,
pubmed-meshheading:11137238-Polyesters,
pubmed-meshheading:11137238-Polyglycolic Acid,
pubmed-meshheading:11137238-Polymers,
pubmed-meshheading:11137238-Tetanus Toxoid
|
pubmed:year |
2000
|
pubmed:articleTitle |
Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.
|
pubmed:affiliation |
Institute of Pharmaceutical Sciences, ETH Zurich, Winterthurerstr. 190, 8057, Zurich, Switzerland. johansen@pharma.ethz.ch
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|